ExploreWatchlistsPricing
  1. JP-listed companies
  2. JCR Pharmaceuticals Co.,Ltd.
  3. Financials
  4. Inventories

JCR Pharmaceuticals Co.,Ltd. (4552)

Market cap
¥79.9B
P/E ratio
47x
JCR Pharma develops and manufactures pharmaceutical and regenerative medicine products for healthcare providers worldwide, with specialized focus on advanced regenerative treatments.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndInventories (Million JPY)YoY (%)
Mar 31, 20252,571+21.79%
Mar 31, 20242,111+92.26%
Mar 31, 20231,098-48.23%
Mar 31, 20222,121+55.16%
Mar 31, 20211,367+55.34%
Mar 31, 2020880-61.42%
Mar 31, 20192,281+29.68%
Mar 31, 20181,759+0.10%
Mar 31, 20171,757+11.04%
Mar 31, 20161,582+3.92%
Mar 31, 20151,523

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat